Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its pandemic influenza shots. The financial package will provide additional ...
Results that may be inaccessible to you are currently showing.